Table 3.
Comparison between MS patients on interferon and fingolimod regarding main study variables.
| MS patients on interferon B n = 18 Mean ± SD | MS patients on fingolimod n = 25 Mean ± SD | P | |
|---|---|---|---|
| Age | 31.4 ± 7.6 | 33.8 ± 9.0 | 0.158 | 
| Disease duration | 55.5 ± 51. 8 | 39.1 ± 30.0 | 0.129 | 
| Relapse number | 3.1 ± 2.1 | 4.4 ± 2.5 | 0.043 | 
| EDSS | 3.5 ± 1.7 | 3.7 ± 2.0 | 0.235 | 
| FSS | 4.3 ± 1.6 | 4. 7 ± 2.1 | 0.192 | 
| Whole brain volume | 1204.3 ± 76. 4 | 1203.9 ± 88.5 | 0.314 | 
| Total lesion volume | 17.7 ± 15.4 | 25.5 ± 17.50 | 0.065 |